Skip to main content
. 2016 Apr 20;127(25):3281–3290. doi: 10.1182/blood-2015-12-684498

Table 1.

Patient cohort

Total Lowest DC ≤30% DC always >30% P value
n 103 56 47
Male/female, % 65/35 70/30 60/40 NS
Age at diagnosis, months, median (range) 5 (0-288) 5 (1-288) 4 (0-144) NS
Patient with HLH onset in infancy, % 67 61 74 NS
Age at HSCT, months, median (range) 12 (2-236) 12 (3-326) 10 (2-150) NS
Distribution of defects, % of group
 FHL2 15 14 17 NS
 FHL3 27 31 23 NS
 FHL4 3 2 4 NS
 FHL5 16 23 9 NS
 GS2 9 5 13 NS
 CHS 3 5 0 NS
 XLP1 5 2 9 NS
 XIAP deficiency (XLP2) 4 4 4 NS
 Others/not known, diagnosed clinically 18 14 21 NS
Donor, % of group
 Matched related donor 24 18 32 NS
 Matched unrelated donor 45 44 45 NS
 Mismatched donor 29 34 23 NS
 Haploidentical donor 2 4 0 NS
Conditioning regimen, % of group
 MAC 25 27 23 NS
 RIC 74 71 77 NS
 Other 1 2 0 NS

Patient characteristics are shown for the entire cohort, for patients in whom the lowest DC was ≤30%, and for patients in whom DC was always >30%. There were no significant differences between both groups.

NS, not significant.